Lytham Partners

We are a full-service IR firm providing expertise & guidance to small-cap companies. Please read our disclaimer at

[Lytham Partners @LythamIR]

SenesTech Expands Distribution of Evolve® Rodent Birth Control™ into Bermuda. Read more: https://t.co/Qdn6HpLu4q $SNES

[Lytham Partners @LythamIR]

Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event. Read more: https://t.co/0P2IIcslSc $CVKD

[Lytham Partners @LythamIR]

PolyPid Completes New Drug Application Submission to FDA for D-PLEX. Read more: https://t.co/p2I8yEjvhz. $PYPD

[Lytham Partners @LythamIR]

Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026. Read more: https://t.co/scr8DsJOby $DYAI

[Lytham Partners @LythamIR]

IPM to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026. Read more: https://t.co/9ZoC1F1H5h $IPM

[Lytham Partners @LythamIR]

Heliostar Publishes Inaugural Sustainability Report. Read more: https://t.co/t99oTdxbjL $HSTR.NE $HSTR.V

[Lytham Partners @LythamIR]

SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026. Read more: https://t.co/4htOBbw9IN $SNES

[Lytham Partners @LythamIR]

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026. Read more: https://t.co/99K7C1E10p $CVKD

[Lytham Partners @LythamIR]

Zoomd Technologies to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026. Read more: https://t.co/rI5Z4fCohO $ZOMD.V

[Lytham Partners @LythamIR]

Intelligent Protection Management Corp. Launches IPM Private Cloud AI Offering. Read more: https://t.co/WTywl4XlV3 $IPM

[Lytham Partners @LythamIR]

Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026. Read more: https://t.co/SUq5qE5PmU $POCI

[Lytham Partners @LythamIR]

Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026. Read more: https://t.co/hDrhO9Rvg6 $AYTU

[Lytham Partners @LythamIR]

SenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels. Read more: https://t.co/0PElgER5r3 $SNES

[Lytham Partners @LythamIR]

Heliostar Files Technical Report for Goldstrike Project. Read more: https://t.co/5SmPlYp7Qh $HSTR.NE $HSTXF

[Lytham Partners @LythamIR]

LiqTech Secures New Record Order for 10 QlariFlow™ Systems for Australian Commercial Pool Project. Read more: https://t.co/nmwB6ZsjoD $LIQT

[Lytham Partners @LythamIR]

Precision Optics Announces Receipt of $3.5 Million Follow-On Production Order for Single-Use Ophthalmic Program. Read more: https://t.co/sAkNJFvwtc $POCI

[Lytham Partners @LythamIR]

Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT). Read more: https://t.co/himI890NgJ $CVKD

[Lytham Partners @LythamIR]

LiqTech Expands Commercial Pool Business Through Strategic Partnership with Lotec and Secures Largest QlariFlow™ Pool Project to Date. Read more: https://t.co/Cab3nphDg8 $LIQT

[Lytham Partners @LythamIR]

PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting. Read more: https://t.co/vNCzVZIvgG $PYPD

[Lytham Partners @LythamIR]

NeurAxis Expands Payer Coverage with Four New Medical Policies. Read more: https://t.co/fDepbv5ADn $NRXS